ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Mississippi » Psychiatry

Top Psychiatry Prescribers in Mississippi

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
PAUL MCGINNIS M.D.

Psychiatry

11,803

$1.63M

762
86 are 65+

3%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 1%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

25%
prescriptions for brand name drugs

Avg: 25%

$138
Average prescription price

Avg: $133

JAMES LAMOUSIN M.D.

Psychiatry

8,622

$2.26M

528
56 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 1%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

32%
prescriptions for brand name drugs

Avg: 25%

$262
Average prescription price

Avg: $133

WILLIAM WELCH MD

Psychiatry

8,221

$1.24M

658
150 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 1%

12%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

23%
prescriptions for brand name drugs

Avg: 25%

$151
Average prescription price

Avg: $133

ROGER ANASTASIO M.D.

Psychiatry

7,379

$1.52M

464
68 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 1%

12%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

26%
prescriptions for brand name drugs

Avg: 25%

$206
Average prescription price

Avg: $133

ROBERT HARDY M.D.

Psychiatry

7,088

$994K

423
58 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 1%

18%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

24%
prescriptions for brand name drugs

Avg: 25%

$140
Average prescription price

Avg: $133

RAYMOND OVERSTREET M.D.

Psychiatry

7,068

$877K

488
143 are 65+

3%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 1%

12%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

20%
prescriptions for brand name drugs

Avg: 25%

$124
Average prescription price

Avg: $133

KHARI OMOLARA M.D.

Psychiatry

6,114

$463K

263
47 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 1%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

16%
prescriptions for brand name drugs

Avg: 25%

$76
Average prescription price

Avg: $133

TERRY JORDAN MD

Psychiatry

5,794

$545K

478
155 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 1%

6%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

21%
prescriptions for brand name drugs

Avg: 25%

$94
Average prescription price

Avg: $133

ERIC WARREN M.D.

Psychiatry

5,575

$658K

436
56 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 1%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

20%
prescriptions for brand name drugs

Avg: 25%

$118
Average prescription price

Avg: $133

KHALED ABU-HAMDAN M. D.

Psychiatry

5,179

$444K

409
50 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 1%

22%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

13%
prescriptions for brand name drugs

Avg: 25%

$86
Average prescription price

Avg: $133

ARVINDER KAUL MD

Psychiatry

5,171

$1M

322
108 are 65+

9%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 1%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

43%
prescriptions for brand name drugs

Avg: 25%

$194
Average prescription price

Avg: $133

FRANKIE STANLEY M.D.

Psychiatry

4,572

$729K

314
27 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 1%

6%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

24%
prescriptions for brand name drugs

Avg: 25%

$159
Average prescription price

Avg: $133

PAUL PYLES MD

Psychiatry

4,316

$524K

398
69 are 65+

7%
patients receiving schedule two controlled substances

Avg: 1%

5%
patients receiving schedule three controlled substances

Avg: 1%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

22%
prescriptions for brand name drugs

Avg: 25%

$121
Average prescription price

Avg: $133

JOSEPH KWENTUS MD

Psychiatry

4,312

$808K

424
54 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 1%

5%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

29%
prescriptions for brand name drugs

Avg: 25%

$187
Average prescription price

Avg: $133

GEORGE DAVIS M.D.

Psychiatry

3,942

$554K

270
22 are 65+

7%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 1%

14%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

25%
prescriptions for brand name drugs

Avg: 25%

$140
Average prescription price

Avg: $133

CLYDE GLENN M.D.

Psychiatry

3,580

$570K

398
87 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 1%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

27%
prescriptions for brand name drugs

Avg: 25%

$159
Average prescription price

Avg: $133

AKIF KHAWAJA M.D.

Psychiatry

3,536

$432K

215
59 are 65+

9%
patients receiving schedule two controlled substances

Avg: 1%

7%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

28%
prescriptions for brand name drugs

Avg: 25%

$122
Average prescription price

Avg: $133

MELINDA JACKSON M. D.

Psychiatry

3,511

$426K

78
19 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

20%
prescriptions for brand name drugs

Avg: 25%

$121
Average prescription price

Avg: $133

ISHAM EVANS M. D.

Psychiatry

3,486

$524K

292
48 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 1%

9%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

23%
prescriptions for brand name drugs

Avg: 25%

$150
Average prescription price

Avg: $133

ROBERT LUNDY M.D.

Psychiatry

3,463

$529K

300
56 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 1%

15%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

26%
prescriptions for brand name drugs

Avg: 25%

$153
Average prescription price

Avg: $133

KRISHAN GUPTA M.D.

Psychiatry

3,276

$435K

285
73 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 1%

6%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

27%
prescriptions for brand name drugs

Avg: 25%

$133
Average prescription price

Avg: $133

FAWAZ ABDRABBO M.D.

Psychiatry

2,947

$252K

214
46 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 1%

7%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

15%
prescriptions for brand name drugs

Avg: 25%

$86
Average prescription price

Avg: $133

ANDREW BISHOP MD

Psychiatry

2,904

$234K

255
65 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 1%

6%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

18%
prescriptions for brand name drugs

Avg: 25%

$80
Average prescription price

Avg: $133

SAVIRA SIDHU MD

Psychiatry

2,830

$338K

206
41 are 65+

5%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 1%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

23%
prescriptions for brand name drugs

Avg: 25%

$119
Average prescription price

Avg: $133

JEFFREY MCGILBRA MD

Psychiatry

2,764

$254K

336
176 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

28%
prescriptions for brand name drugs

Avg: 25%

$92
Average prescription price

Avg: $133

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank